- Visibility 134 Views
- Downloads 104 Downloads
- Permissions
- DOI 10.18231/j.ajmpr.v.3.i.1.7
-
CrossMark
A concise review- An analytical method development and validation of loratadine
- Author Details:
-
Pritam Jain *
-
Ashish Chaudhari
-
Udaysing Girase
-
Nitin Haswani
Pritam Jain *
One to one and a half hours is when peak plasma concentrations of the long-acting antihistamine loratadine, which is quickly absorbed when taken orally, reach. There is no discernible buildup after repeated dosages, and its pharmacokinetics are dose proportional. Similar in its kinetics, descarboethoxy-loratadine (DCL), the primary metabolite, is likewise pharmacologically active. Poop and urine are the main ways that the medication is eliminated after significant metabolism.
This study focuses on the most current advancements in analytical methods for figuring out the presence of loratadine in different biological media, such as human plasma and urine, as well as in bulk and commercial dose forms. High performance liquid chromatography (HPLC), high performance thin layer chromatography (HPTLC), liquid chromatography linked to tandem mass spectrometry (LC-MS), and electrophoresis will all be thoroughly examined in this paper. Matrix, stationary phase, mobile phase composition, RF value for detection wavelength, retention time, DL, carrier gas, flow rate, capillaries wavelength, separation voltage, temperature, and pressure are some of the factors that are included in these procedures.
References
- Al Masoud N, Bakheit AH, Alshammari MFM, Abdel-Aziz HA, AlRabiah H. Loratadine. Profiles Drug Subst Excip Relat Methodol. 2022; 47:55–90.
- Chu Z, Cen L, Xu Q, Lin G, Mo J, Shao L, et al. Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases. Eur J Med Chem. 2024; 268:116197.
- Fernández H, Rupérez FJ, Barbas C. Capillary electrophoresis determination of loratadine and related impurities. J Pharm Biomed Anal. 2003;31(3):499–506.
- Yin OQ, Shi X, Tomlinson B, Chow MS. Effect of CYP2D6* 10 allele on the pharmacokinetics of loratadine in Chinese subjects. Drug Metab Disp. 33(9):1283-7.
- El Ragehy NA, Badawey AM, Khateeb SZE. Stability indicating methods for the determination of loratadine in the presence of its degradation product. J Pharm Biomed Anal. 2002;28(6):1041–53.
- Clissold SP, Sorkin EM, Goa KL. Loratadine Drugs. 1989;37(1):42–57.
- Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, et al. Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica. 2005;35(2):155–89.
- Ghosal A, Gupta S, Ramanathan R, Yuan Y, Lu X, Su A. Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites. Drug Metab Lett. 2009;3(3):162–70.
- Ramanathan R, Reyderman L, Kulmatycki K, Su AD, Alvarez N, Chowdhury SK. et al. Disposition of loratadine in healthy volunteers. Xenobiotica. 2007;37(7):753–69.
- Picard N, Dridi D, Sauvage F, Boughattas NA, Marquet P. General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism. J Sep Sci. 2009;32(13):2209–17.
- Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S. et al. Pharmacokinetics and dose proportionality of loratadine. J Clin Pharmacol. 1987;27(9):694-8.
- DuBuske LM. Pharmacokinetics/pharmacodynamics and psychomotor performance aspects of antihistamine therapies. Clin Applied Immunol Rev. 2001;1(5):277-89.
- Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S, Zampaglione N. Pharmacokinetics and dose proportionality of loratadine. J Clin Pharm. 1987;27(9):694-8.
- Clissold SP, Sorkin EM, Goa KL. Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1989;37(10:42-57.
- Hilbert J, Moritzen V, Parks A, Radwanski E, Perentesis G, Symchowicz S. et al. The pharmacokinetics of loratadine in normal geriatric volunteers. J Int Med Res. 1988;16(1):50-60.
- Matzke GR, Halstenson CE, Opsahl JA, Hilbert J, Perentesis G, Radwanski E, Zampaglione N. Pharmacokinetics of loratadine in patients with renal insufficiency. J Clin Pharmacol. 1990;30(4):364-
- Radwanski E, Hilbert J, Symchowicz S, Zampaglione N. Loratadine: multiple‐dose pharmacokinetics. J Clin Pharma. 1987;27(7):530-3.
- Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S. et al. Pharmacokinetics and dose proportionality of loratadine. J Clin Pharmacol. 1987;27(9):694-8.
- Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol. 1988;28(3):234-9.
- Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, Patrick J. Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica. 2005;35(2):155-89.
- Li C, Kim M, Choi JS. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous 58 Jain et al. / African Journal of Medicine and Pharma Research 2025;3(1):46-59 administration of loratadine in rats. Arch Pharm Res. 2010;33:1395-
- Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB. et al. Disposition of desloratadine in healthy volunteers. Xenobiotica. 2007;37(7):770-87.
- Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review. Clin Pharmacokinetics. 2008;47:217-30.
- Renwick AG. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes. Clin Experimen Allergy. 1999;29:116-24.
- Barecki ME, Casciano CN, Johnson WW, Clement RP. In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OH-desloratadine for five human cytochrome P-450 enzymes. Drug Metab Disp. 2001;29(9):1173-5.
- Pavalache G, Dorneanu V, POPESCU A. Development of an Analytical Method Based on The High-Performance Liquid Chromatography for Determination of Loratadine. Farmacia. 2011;59:200-8.
- Ramulu G, Kumar YR, Vyas K, Suryanarayana MV, Mukkanti K. A new validated liquid chromatographic method for the determination of loratadine and its impurities. Sci Pharmaceutica. 2011;79(2):277
- Yin OQ, Shi X, Chow MS. Reliable and specific high-performance liquid chromatographic method for simultaneous determination of loratadine and its metabolite in human plasma. J Chromatogra B. 2003;796(1):165-72.
- El-Sherbiny DT, El-Enany N, Belal FF, Hansen SH. Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent. J Pharm Biomed Anal. 2007;43(4):1236-42.
- Guptha A, Vnarayanareddy V, Peera S, Ratnakumari P, Jayasanthi N, Vijaya A. et al. New RP-HPLC method developmetn and validation for the analysis of loratadine in formulations. Int J Res Rev Sci. 2011;1:179-85.
- Lu J, Wei YC, Markovich RJ, Rustum AM. Development and validation of a novel stability-indicating reversed-phase high- performance liquid chromatography method for assay of loratadine and determination of its related compounds. J AOAC Int. 2010;93(3):891-903.
- Kunicki PK. Determination of loratadine in human plasma by high- performance liquid chromatographic method with ultraviolet detection. J Chromatography B: Biomed Sci Appl. 2001;755(1- 2):331-5.
- Abu-Lathou A, Hamdan II, Tahraoui A. A new HPLC approach for the determination of hydrophilic and hydrophobic components: the case of pseudoephedrine sulfate and loratadine in tablets. Drug Dev Indus Pharm. 2005;31(6):577-88.
- Rane SS, Padmaja P. Spectrophotometric and HPLC method for quantification of Loratadine on swabs for cleaning validation. Toxicolo Environ Chem. 2013;95(2):232-6.
- Mabrouk MM, El-Fatatry HM, Hammad S, Wahbi AA. Simultaneous determination of loratadine and pseudoephedrine sulfate in pharmaceutical formulation by RP-LC and derivative spectrophotometry. J Pharma Biomed Anal. 2003;33(4):597-604.
- Amini H, Ahmadiani A. Rapid determination of loratadine in small volume plasma samples by high -performance liquid chromatography with fluorescence detection. J Chromatog B. 2004;809(2):227-30.
- Lu J, Wei YC, Markovich RJ, Rustum AM. The retention behavior of loratadine and its related compounds in ion pair reversed phase HPLC. J Liquid Chroma Related Technol. 2010;33(5):603-14.
- El-Enany N, El-Sherbiny D, Belal F. Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma. Chem Pharma Bull. 2007;55(12):1662-70.
- Radhakrishna T, Narasaraju A, Ramakrishna M, Satyanarayana AJ. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J Pharma Biomed Anal. 2003;31(2):359-68.
- Ulavapalli KR, Sriramulu J, Mallu UR, Bobbarala V. Simultaneous determination of psuedoephedrine, fexofenadine and loratadine in pharmaceutical products using high resolution RP-HPLC method. J Pharm Res. 2011;4(4):1219-21.
- Plenis A, Konieczna L, Olędzka I, Kowalski P. Rapid analysis of loratadine in human serum by high-performance liquid chromatography with fluorescence detection. Acta Chromatograph. 2010;22(1):69-79.
- Pavalache G, Dorneanu V, Popescu A, Validation and Application of a New DAD-HPLC Method for Determination of Loratadine from Pharmaceuticals. Farmacia. 2015;63(3):366-70.
- Gandhi BM, Rao AL, Rao JV. Method development and validation for simultaneous estimation of Montelukast sodium and Desloratadine by RP-HPLC. Am J Anal Chem. 2015;6(8):651-8.
- Al-Salman HN, Qasim QA, Fayadh RH, Hussein HH. Modern chromatographic method for estimating Loratadine and affections on healthcare. Int J Hum Rights Healthcare. 2024;17(4):507-20.
- Naganjaneyulu R. Method development and validation of pseudoephedrine hcl and loratadine by rp-hplc in bulk and tablet dosage form. 2015:4(6):1143-50.
- Sailaja G, Babu BH. A validated high performance liquid chromatography method for the simultaneous analysis of guaifenesin, ambroxol and loratidine in bulk and liquid dosage form. J Applied Pharma Sci. 2015;5(12):061-6.
- Swarnalatha N, Maravajhala V. Development and validation of a HPLC method for estimation of loratadine and its application to a pharmacokinetic study. Current Sci. 2019;116(2):243-8.
- Mamina OO, Kabachny N, Bondarenko Y . Lozova OV, Identification and the quantitative determination of loratadine by the HPLC method, J Oranic and Pharm Chem, 2021;193(75):40-6.
- Patel RB, Patel MR, Mehta JB. Validation of stability indicating high performance liquid chromatographic method for estimation of Desloratadine in tablet formulation. Arabian J Chemi. 2017;10: S644-50.
- Chaudhry H, Rangra NK. Development and validation of a stability indicating green analytical method for the simultaneous estimation of l-glutathione, n-acetyl l-cysteine and Vitamin C in marketed formulation using UV–visible spectroscopy. Future J Pharma Sci. 2023;9(1):74.
- Reid IO, Gadkariem EA. Simultaneous determination of pseudoephedrine and loratadine in syrups by HPLC using cation exchange column and experimental design optimization. Pharma Innov. 2017;6(3):244.
- Belal F, Abd El-Razeq S, El-Awady M, Zayed S, Barghash S. Rapid micellar HPLC analysis of loratadine and its major metabolite desloratadine in nano-concentration range using monolithic column and fluorometric detection: Application to pharmaceuticals and biological fluids. Chem Cent J. 2016;10:1-1.
- Vani R, Kumar BV, Mohan GK. Analytical method development and validation for the determination of loratadine, ambroxol hydrochloride and guaiphenesin using reverse phase HPLC method in bulk and liquid dosage form. J Global Trends Pharma Sci. 2014;5:2248-52.
- Pavalache G, Dorneanu V, Popescu A. A New HPLC Method for the Separation and Quantitative Determination of Loratadine. Revista De Chimie. 2016;67(1):30-3.
- Kale P, Jadhav A, Nagrale S, Pondkule A, Babar V, Sonavane V. Development and Validation of Stability Indicating Rp-Hplc Method for Estimation of Loratadine in API and its Formulation. Neuro Quantol. 2022;20(17):323.
- Sher N, Siddiqui FA, Hasan N, Shafi N, Zubair A, Mirza AZ. Simultaneous determination of antihistamine anti-allergic drugs, cetirizine, domperidone, chlorphenamine maleate, loratadine, meclizine and buclizine in pharmaceutical formulations, human serum and pharmacokinetics application. Anal Methods. 2014;6(8):2704-14.
- Roge AB, Firke SN, Sarje SK, Ghante MH, Shendarkar GR, Ghiware NB. Development, Validation of RP-HPLC Method and GC MS Analysis of Desloratadine HCL and It’s Degradation Products. Int J Cur Res Rev.| 2021;13(21):129. 59 Jain et al. / African Journal of Medicine and Pharma Research 2025;3(1):46-59
- Ashraf M, Shahzad MN, Hayat MM, Rahman J, Ejaz S, Altaf H, Nasim FH. Development and Validation of an HPLC Method for the Quantification of Sitagliptin in Plasma and Tablet Dosage Form. Lat Am J Pharm. 2015;34(3):456-61.
- Sebaiy MM, Ziedan NI. Developing a High-performance Liquid Chromatography Method for Simultaneous Determination of Loratadine and its Metabolite Desloratadine in Human Plasma. Current drug metabolism. 2019;20(13):1053-9.
- Qadir MA, Ahmed M, Tahir MS, Shakoor A, Shafiq MI, Shahzad S, Ali A. Sensitive and selective UPLC method for simultaneous determination of methyl paraben, propyl paraben and loratadine in antihistamine suspension and biological samples: stability indicating assay. Latin Am J Pharm. 2016;35(5):869-76.
- Youssef RM, Khamis EF, El-Sayed MA, Moneim MM. Validated HPTLC method for simultaneous determination of loratadine and desloratadine in presence of Co-formulated drug. JPC–Journal of Planar Chromatography–Modern TLC. 2012; 25:456-62.
- Magar S, Biyani K. Development and validation of stability indicating hptlc method for simultaneous estimation of ambroxol hydrochloride and loratadine in pharmaceutical dosage form. 2022: 01: 2394-0573.
- Zhang D, Strock J, Sherma J. Transfer of TLC Screening Methods Fot Azithromycin, Imipramine HCl, and Sulfadoxine þ Pyrimethamine Tablets to Quantitative HPTLC-Densitometry Methods. J. Liq. Chromatogr Relat Technol. 2016;39, 277–80.
- Farid NF, Abdelaleem EA. HPTLC method for the determination of paracetamol, pseudoephedrine and loratidine in tablets and human plasma. J Chrom Sci. 2016;54(4):647-52.
- Patel RB, Patel MR, Mehta JB. Development and Validation of HPTLC Method for Estimation of Desloratadine. Int J Biomed Pharma Sci.2013;7(1):33-7.
- Verma S, Singh SK. LC-ESI-MS/MS estimation of loratadine- loaded self-nanoemulsifying drug delivery systems in rat plasma: Pharmacokinetic evaluation and computer simulations by GastroPlus™. J Pharma Biomed Anal. 2016;124:10-21.
- Zhang Y, Lu Y, Wang L, Tian Y, Zhang Z. Pharmacokinetics and tissue distribution of loratadine, desloratadine and their active metabolites in rat based on a newly developed LC-MS/MS analytical method. Drug Res. 2020;70(11):528-40.
- Sutherland FC, De Jager AD, Badenhorst D, Scanes T, Hundt HK, Swart KJ. Et al. Sensitive liquid chromatography–tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma. J Chromat A. 2001;914(1-2):37-43.
- Salem II, Idrees J, Al Tamimi JI. Determination of loratadine in human plasma by liquid chromatography electrospray ionization ion-trap tandem mass spectrometry. J Pharma Biomed Anal. 2004;34(1):141-51.
- Fernandez H, Ruperez FJ, Barbas C. Capillary electrophoresis determination of loratadine and related impurities. J Pharma Biomed Anal. 2003;31(3):499-506.
- Mikuš P, Kubačák P, Valášková I, Havránek E. Caillary zone electrophoresis determination of loratadine in tablets. Die Pharmazie-An Int J Pharm Sci. 2004;59(4):260-2.
- Mothé CM, Souza AD, Singh AK, Bou-Chacra NA, Aurora-Prado MS. Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine. Braz J Pharma Sci. 2022;58:e20767.
- Sakhare RS, Sanjay SP, Tukaram VG. Development and validation of stability indicating area under curve method for simultaneous estimation of ambroxol hydrochloride and loratadine in bulk and tablet dosage form. Pharm Lett. 2016; 8:208-15.
- Hassaninejad-Darzi SK, Samadi-Maybodi A, Nikou SM. UV-vis spectrophotometry and multivariate calibration method for simultaneous determination of theophylline, montelukast and loratadine in tablet preparations and spiked human plasma. Iranian J Pharma Res: IJPR. 2016;15(3):379.
- Youssef R, Khamis E, El-Sayed M, Mohamed M, Moneim A. Simultaneous Determination of Loratadine and Desloratadine in Presence of Pseudoephedrine using Validated Spectrophotometric Methods. Int J Chem Biomed Sci. 2017; 3:1-9.
- Afreen SS, Anumolu PD, Shakar PV, Tulasi JR, Barla KD, Dumpala VD. Discriminating derivative spectrophotometric concurrent quantification of loratadine and ambroxol in tablet dosage form. 2023:14(7):3470-74.
- Prathap B, Arivazhagan M, Arikaran S, Arthi R, Arshad Khan M, Balajeevarshan KN. Et al. Analytical method development and validation for the estimation of loratadine using uv- spectrophotometer (2023):701-714.
- Roge A, Shendarkar G, Ghante M, Ghiware N. Development of Validated UV Spectrophotometric Stability Indicating Method for Estimation of Desloratadine from Its Tablet Dosage Form. Int J Pharma Biol Sci. 2019;9(3):1174-81.